Opus Genetics, Inc. 8-K

What Happened

• Opus Genetics, Inc. (ticker: IRD), a Delaware corporation, announced its financial results for the fiscal year ended December 31, 2025 via a press release dated March 10, 2026. The company filed an 8‑K (Item 2.02) to furnish that press release (Exhibit 99.1) and incorporated it by reference.

Key Details

• Filing/Date: Form 8‑K filed March 10, 2026, reporting results for the fiscal year ended December 31, 2025.
• Disclosure: Press release furnished as Exhibit 99.1; Cover Page Interactive Data file submitted as Exhibit 104.1 (Inline XBRL).
• Item cited: Item 2.02 — Results of Operations and Financial Condition (press release furnished, not an amended periodic report).

Why It Matters

• This 8‑K signals Opus Genetics has publicly released its full-year financial performance (earnings/revenue/other metrics) for FY 2025; investors should read the furnished press release (Exhibit 99.1) for the specific figures and management commentary. Because the release is furnished under Item 2.02, the company is providing timely results that may affect trading and investor expectations, but the 8‑K itself does not amend prior periodic reports — the press release contains the detailed financials.